Search
Chemomab Therapeutics Ltd
CMMBAdd to Watchlist
2.600USD
-0.090-3.35%
Close 09-10 16:00（ET）
75.64MMarket Cap
14.98P/E TTM
After-hours (ET)0.000USD0.000
After-hours (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.35%
5 Days
-8.13%
1 Month
+37.57%
6 Months
+31.31%
Year to Date
+57.58%
1 Year
-13.04%
Key Figures
2.665Open
2.700High
1.06KVolume
14.98P/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
2.690Prev. Close
2.590Low
2.79KTurnover
LossP/E Static
8.71P/B
0.00%Div Yield TTM
-60.46%ROA
3.58052wk High
0.01Volume Ratio
-13.95MNet Profit
28.98MShares
0.1742EPS TTM
0.61Beta
-70.61%ROE
1.35052wk Low
2.23%Amplitude
--Gross Margin
75.64MMarket Cap
5.10Reward/Risk
5.66%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Chemomab Therapeutics Ltd Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.27/-0.15
Revenue / Forecast
--/0.00
Chemomab Therapeutics Ltd Profile
SectorBiotechnology & Medical Research
Ticker SymbolCMMB
Number of employees16
CountryIsrael
Ownership
| Shareholders | Proportion |
|---|---|
| Otto (Erik) | 5.35% |
| Apeiron Investment Group Ltd | 3.93% |
| Rivendell Investments 2017-9 LLC | 3.85% |
| Citadel Advisors LLC | 1.44% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 7.65% |
| Family Office | 3.93% |
| Corporation | 3.85% |
| Hedge Fund | 3.27% |
Related Instruments
-0.11%
-0.27%
+1.72%
+1.63%
-1.91%
0.00%
-2.25%
-0.58%
-0.47%
-1.23%
-1.26%
-1.02%
-0.30%
-1.21%
-1.05%
-1.78%
-1.82%
-0.55%
-1.66%
+0.74%Popular Instruments
52219.700
+165.200 (+0.32%)
29130.200
+15.900 (+0.06%)
7609.900
+14.100 (+0.19%)
14438.000
-18.000 (-0.13%)
63818.000
-259.000 (-0.40%)
6274.300
+16.200 (+0.26%)
100.027
-2.538 (-2.48%)
326.570
+11.230 (+3.56%)
218.360
-5.060 (-2.26%)
4335.010
+18.200 (+0.42%)
FAQs
What is the current price of Chemomab Therapeutics Ltd (CMMB)?
The current price of Chemomab Therapeutics Ltd (CMMB) is 2.60.
What is the symbol of Chemomab Therapeutics Ltd?
The ticker symbol of Chemomab Therapeutics Ltd is CMMB.
What is the 52-week high of Chemomab Therapeutics Ltd?
The 52-week high of Chemomab Therapeutics Ltd is 3.58.
What is the 52-week low of Chemomab Therapeutics Ltd?
The 52-week low of Chemomab Therapeutics Ltd is 1.35.
What is the market capitalization of Chemomab Therapeutics Ltd?
The market capitalization of Chemomab Therapeutics Ltd is 75.64M.
Is Chemomab Therapeutics Ltd (CMMB) currently rated as Buy, Hold, or Sell?
According to analysts, Chemomab Therapeutics Ltd (CMMB) has an overall rating of STRONG BUY, with a price target of 5.00.
What is the Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB)?
The Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB) is 0.17.